Publications
- In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death +12009 | Faculty of Medicine in Hradec Králové
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo +12008 | Faculty of Medicine in Hradec Králové
- In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity +12007 | Faculty of Medicine in Hradec Králové
- Cardiac troponin T as a biochemical marker of anthracycline-induced cardiotoxicity in vivo +12007 | Faculty of Medicine in Hradec Králové
- New iron chelators in anthracycline-induced cardiotoxicity +12007 | Faculty of Medicine in Hradec Králové
- Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study +12005 | Faculty of Medicine in Hradec Králové
- Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Loading network view...